HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inter Parfums

This article was originally published in The Rose Sheet

Executive Summary

Fragrance marketer will offer 4,336,050 shares of its common stock in a public offering, firm says Oct. 10. Selling stockholders are LV Capital USA, Inc. (3,436,050 shares), CEO Jean Madar (450,000 shares) and President Philippe Benacin (450,000 shares), according to Inter Parfums. Madar and Benacin additionally will "grant to the underwriters a 30-day option to purchase up to an additional 650,408 shares of Inter Parfums common stock to cover over-allotments, if any," company notes, adding firm "will not receive any proceeds of the sale of its common stock by the selling stockholders." Offering will be managed by Oppenheimer & Co. and SG Cowen & Co., LLC, with Citigroup Corporate and Investment Banking acting as book runner...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel